RHHBY
OTC · Healthcare
Roche Holding AG
$47.39
-1.03 (-2.12%)
Financial Highlights (FY 2026)
Revenue
387.82B
Net Income
82.47B
Gross Margin
73.9%
Profit Margin
13.7%
Rev Growth
-1.2%
D/E Ratio
0.98
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | |
|---|---|---|
| Gross Margin | 73.9% | 73.9% |
| Operating Margin | 21.9% | 19.7% |
| Profit Margin | 13.7% | 13.0% |
Income Statement
| FY 2026 | FY 2025 | |
|---|---|---|
| Revenue | 387.82B | 392.69B |
| Gross Profit | 286.64B | 290.24B |
| Operating Income | 84.97B | 77.43B |
| Net Income | 82.47B | 75.15B |
| Gross Margin | 73.9% | 73.9% |
| Operating Margin | 21.9% | 19.7% |
| Profit Margin | 13.7% | 13.0% |
| Rev Growth | -1.2% | -1.2% |
Balance Sheet
| FY 2026 | FY 2025 | |
|---|---|---|
| Total Debt | 63.83B | 63.83B |
| Total Equity | 65.01B | 65.01B |
| D/E Ratio | 0.98 | 0.98 |
Cash Flow
| FY 2026 | FY 2025 | |
|---|---|---|
| EBITDA | 110.61B | 106.40B |
| Free Cash Flow | — | — |